Podcasts about diagnostics

00:00:00 - Surf's Up: Season 6 Episode 7Host Roger Green explains our recent vacation from publishing episodes, assures the audience that the podcast will continue weekly for months and years ahead, and discusses the episode's sections, covering the Global Think-Tank on Steatotic Liver Disease (SLD), the EASL patient screening activity and the increasing role of NITs in drug development. While introducing roundtable guests, he introduces first-time Surfer Dr. Kristina Curtis of the UK-based consultancy, Applied Behaviour Change.00:09:11 - Roundtable I: From the Global Think-Tank on SLDThis discussion starts with co-host Jörn Schattenberg discussing the history and evolution of the first four Global Think-Tanks as the focus shifts from educating medical professionals about liver disease to incorporating a broader group of stakeholders, including politicians and non-hepatologist MDs, to break down siloes and create wider awareness. Co-host Louise Campbell describes the breadth of stakeholders necessary to address this pandemic fully. She explains how her work with transient elastography and the MyLife365.me app constitutes a form of behavioral therapy. Jörn describes the test as a diagnostic and comments that the treatment is what health professionals do with the results. Kristina says that the behavioral change that results comes from well-delivered feedback. She describes "hybrid interventions, digital interventions with a human in the loop." Louise discusses results from the EASL late-breaker that support these findings and goes on to discuss the role AI can play in medical practices.00:23:50 - Newsmaker: Jose Willemse, Dutch Liver Patients Association This discussion covers two primary topics: (1) the Amsterdam screening activity that took place during EASL. Jose describes the phenomenal level of interest in this activity, in which hepatologists and APPs scanned 400 people per day for MASLD and MASH. Boosted by significant mass publicity in Amsterdam, the number of people seeking screening exceeded the 400/day quota, with some arriving in line hours before the scheduled start time and others traveling for hours to reach the site. Jose believes that with adequate publicity, efforts like these could be replicated around the world, but that the healthcare system lacks the necessary resources to do so. In terms of patient care, Jose emphasized the importance of sensitive yet frank conversations and helping patients appreciate the successes they are achieving. 00:53:45 - Roundtable II: NITs Increasing Role in Drug Development Sven Francque and Naim Alhouri joined Louise, Jörn and Roger for this roundtable, although Naim had dropped off by this time. The conversation starts with Louise noting that the goal of therapy is not simply to treat MASLD, but to achieve overall metabolic health, of which MASLD is a key component. Jörn states that we are on the path toward conducting clinical trials entirely with NITs as disease markers, which he describes as a "game changer" and Louise terms "exciting." She asks whether NITs can serve as the only trial surrogate. Jörn and Sven agree that we are not at that point yet, but we are headed in that direction. Jörn asserts that "nothing" will replace outcomes as the prerequisite for full approval and mentions the VCTE study group as demonstrating that a large NIT-based trial can prove effects on disease. Louise cautions that operator competency is a key, if overlooked, criterion for this kind of activity. Sven concurs and states that repeat measures are crucial in managing disease. Jörn notes that practices can serve as centers of care, but will need support from nutritionists and other professionals. 01:06:08 - Business ReportRoger highlights special September programming, indicates that new sponsors are on the way, and asks how many listeners find SurfingMASH on YouTube. 

The MacVoices Live! panel discusses Meta's controversial AI photo upload feature and growing privacy concerns, Microsoft's AI diagnostic tool that outperforms doctors, and the retirement of Windows' infamous blue screen of death. Chuck Joiner, David Ginsburg, Brian Flanigan-Arthurs, Eric Bolden, Marty Jencius, Jeff Gamet, Web Bixby, and Jim Rea debate the tradeoffs between utility and privacy, AI's evolving role in medicine, and the implications for education, the arts, and everyday tech users.  This MacVoices is supported by Notion. The best AI tool for work. Try it now at notion.com/macvoices. Show Notes: Chapters: 00:11 Introduction to Mac Voices 01:58 Meta's Photo Upload Dilemma 06:38 Concerns About AI in Art 07:10 Microsoft's New AI Diagnostics 16:38 Humor in Medical Procedures 21:15 The End of the Blue Screen of Death 37:04 Closing Thoughts and Community Engagement Links: Meta wants to upload every photo you have to its cloud to give you AI suggestions https://appleinsider.com/articles/25/06/27/meta-wants-to-upload-every-photo-you-have-to-its-cloud-to-give-you-ai-suggestions Microsoft Says Its New AI System Diagnosed Patients 4 Times More Accurately Than Human Doctors https://www.wired.com/story/microsoft-medical-superintelligence-diagnosis/ Windows is getting rid of the Blue Screen of Death after 40 years https://www.theverge.com/news/692648/microsoft-bsod-black-screen-of-death-color-change-official Guests: Web Bixby has been in the insurance business for 40 years and has been an Apple user for longer than that.You can catch up with him on Facebook, Twitter, and LinkedIn. Eric Bolden is into macOS, plants, sci-fi, food, and is a rural internet supporter. You can connect with him on Twitter, by email at embolden@mac.com, on Mastodon at @eabolden@techhub.social, on his blog, Trending At Work, and as co-host on The Vision ProFiles podcast. Brian Flanigan-Arthurs is an educator with a passion for providing results-driven, innovative learning strategies for all students, but particularly those who are at-risk. He is also a tech enthusiast who has a particular affinity for Apple since he first used the Apple IIGS as a student. You can contact Brian on twitter as @brian8944. He also recently opened a Mastodon account at @brian8944@mastodon.cloud. Jeff Gamet is a technology blogger, podcaster, author, and public speaker. Previously, he was The Mac Observer's Managing Editor, and the TextExpander Evangelist for Smile. He has presented at Macworld Expo, RSA Conference, several WordCamp events, along with many other conferences. You can find him on several podcasts such as The Mac Show, The Big Show, MacVoices, Mac OS Ken, This Week in iOS, and more. Jeff is easy to find on social media as @jgamet on Twitter and Instagram, jeffgamet on LinkedIn., @jgamet@mastodon.social on Mastodon, and on his YouTube Channel at YouTube.com/jgamet. David Ginsburg is the host of the weekly podcast In Touch With iOS where he discusses all things iOS, iPhone, iPad, Apple TV, Apple Watch, and related technologies. He is an IT professional supporting Mac, iOS and Windows users. Visit his YouTube channel at https://youtube.com/daveg65 and find and follow him on Twitter @daveg65 and on Mastodon at @daveg65@mastodon.cloud. Dr. Marty Jencius has been an Associate Professor of Counseling at Kent State University since 2000. He has over 120 publications in books, chapters, journal articles, and others, along with 200 podcasts related to counseling, counselor education, and faculty life. His technology interest led him to develop the counseling profession ‘firsts,' including listservs, a web-based peer-reviewed journal, The Journal of Technology in Counseling, teaching and conferencing in virtual worlds as the founder of Counselor Education in Second Life, and podcast founder/producer of CounselorAudioSource.net and ThePodTalk.net. Currently, he produces a podcast about counseling and life questions, the Circular Firing Squad, and digital video interviews with legacies capturing the history of the counseling field. This is also co-host of The Vision ProFiles podcast. Generally, Marty is chasing the newest tech trends, which explains his interest in A.I. for teaching, research, and productivity. Marty is an active presenter and past president of the NorthEast Ohio Apple Corp (NEOAC). Jim Rea built his own computer from scratch in 1975, started programming in 1977, and has been an independent Mac developer continuously since 1984. He is the founder of ProVUE Development, and the author of Panorama X, ProVUE's ultra fast RAM based database software for the macOS platform. He's been a speaker at MacTech, MacWorld Expo and other industry conferences. Follow Jim at provue.com and via @provuejim@techhub.social on Mastodon. Support:      Become a MacVoices Patron on Patreon      http://patreon.com/macvoices      Enjoy this episode? Make a one-time donation with PayPal Connect:      Web:      http://macvoices.com      Twitter:      http://www.twitter.com/chuckjoiner      http://www.twitter.com/macvoices      Mastodon:      https://mastodon.cloud/@chuckjoiner      Facebook:      http://www.facebook.com/chuck.joiner      MacVoices Page on Facebook:      http://www.facebook.com/macvoices/      MacVoices Group on Facebook:      http://www.facebook.com/groups/macvoice      LinkedIn:      https://www.linkedin.com/in/chuckjoiner/      Instagram:      https://www.instagram.com/chuckjoiner/ Subscribe:      Audio in iTunes      Video in iTunes      Subscribe manually via iTunes or any podcatcher:      Audio: http://www.macvoices.com/rss/macvoicesrss      Video: http://www.macvoices.com/rss/macvoicesvideorss

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

Join i3 Health for a special live webinar, Optimizing Neuroendocrine Tumor Outcomes: Closing the Gaps in Diagnosis and Care, being held on Thursday, July 17th at 12:00 pm Eastern and on Tuesday, August 5th at 3:00 pm Eastern. In this exclusive event, Dr. Aman Chauhan, Leader of the Neuroendocrine Tumor Program at the University of Miami, Sylvester Comprehensive Cancer Center, will share his expertise and latest insights in the treatment of NETs. In this interview, Dr. Chauhan shares a preview of the topics he is excited to highlight during the webinar, including the recent advances which are transforming patient care, the emerging field of theranostics, the evolving role of multidisciplinary care, and practical tips for effective team collaboration. Don't miss this opportunity to learn from one of the leading voices in NETs care. Register at the link below or scan the QR code in the video to secure your spot. We look forward to seeing you! Register Here! July 17, 2025 @ 12:00 PM ET: https://us02web.zoom.us/webinar/register/WN_2VJ0PmYISae4gAh2KxNlnQ#/registration August 5, 2025 @ 3:00 PM ET: https://us02web.zoom.us/webinar/register/WN_teUE5QgyQJ6sYaLRrkNp9g#/registration

Send us a textIn this conversation, Dr. Kerl interviews VCA's former Vice President of People and Organization, Paola Perez Loaiza. Listen in as she shares her unique journey from engineering to HR leadership in the veterinary field. She discusses the vital role of overseeing People and Organization at VCA Animal Hospitals, emphasizing the importance of culture, associate well-being, and professional development. Paola highlights the significant investments made in associate support, including health resources and internship programs. She also reflects on the Mars Associate Survey's findings and its impact on employee engagement and client experience. As she transitions to a new role at Royal Canin, Paola expresses her excitement for the future of veterinary medicine and the ongoing commitment to world-class care.Paola has held several leadership roles within the Mars Petcare ecosystem, including AniCura P&O head, Vice President for Mars Vet Health International and Diagnostics, and various P&O leadership roles with Mars Global Pet Nutrition and U.S. Pet Nutrition. Before joining Mars, Paola was at Procter & Gamble for 17 years, where she held multiple roles in supply and procurement in Latin America, Europe and North America.Eighteen months ago, Paola's family adopted Zula, a mixed-breed dog from a shelter. She has brought much joy to Paola and her family. This adoption was one of the first success stories of VCA Charities' "Dog Day Out" program. Paola is passionate about finding and nurturing the leaders of tomorrow. She believes that every person needs to find their own definition of happiness and, from there, work hard and persevere in pursuing their dreams. She loves traveling, learning about different cultures and experiencing their gastronomy. Paola, her husband and two children have lived in different countries and cities across Latin America, the US and Europe. She loves spending time with family and friends and doing CrossFit. Paola has accepted the position of Vice President, P&O, Royal Canin European Region and joined the Royal Canin team on June 1, 2025. In this enhanced role, Paola will serve as the P&O Business Partner for the Regional President and the leadership team supporting a multi-year transformation of Royal Canin Europe, the home of 2,700 talented Royal Canin Associates across 28 countries and 10business units. She will also own the strategic direction for global Royal Canin Talent, Leadership and OE agenda.Visit our website: vcavoice.comAll episodes produced by dādy creative

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, share insights from industry news and recent conferences, including PlatforMed. They explore:The significant interest in diagnostics for the advancement of cancer care.The Joint Commission's collaboration with the Coalition for Health AI to establish guidelines for the responsible use of artificial intelligence. The growing understanding that platforms offer an opportunity to expand access and make knowledge more accessible as platform-driven solutions become a reality.The role of laboratorians in guiding the ethical and effective use of data and emerging technologies — and what this means for educating future healthcare professionals.The critical importance of values and ethics in deploying new tools.

Send us a textChris Wood discusses how early diagnostics of lung cancer through artificial intelligence and medical imaging can lead to better survival rates through early intervention. • Lung cancer takes more lives than breast, prostate and colon cancer combined, with approximately 70% of cases caught at late stages• The National Lung Screening Trial showed that screening high-risk populations reduced mortality by 20%• I-ELCAP research demonstrated an 80% twenty-year survival rate for early-stage cancers detected with CT scans and treated surgically• Preventive healthcare is shifting from general advice to personalized screening protocols based on individual risk factors• AI applications in medical imaging now assist with detection, characterization, and triage of disease• Lung biopsies have a 22% complication rate, making non-invasive diagnostic methods particularly valuable• AI-powered imaging can provide additional information to help clinicians decide whether to perform biopsies• In clinical trials, AI imaging analysis could improve patient selection and help trials reach endpoints more efficiently • Medical imaging gives patients visual information about their bodies that can motivate healthier lifestyle changes• The future of healthcare will likely focus on improving quality of life rather than simply extending lifespanIf you have a suggestion for a guest for our show, reach out to Sam Parnell or Ivanna Rosendal on LinkedIn. You can find more episodes on Apple Podcasts, Spotify, Google Podcasts or in any other player.Support the show________Reach out to Ivanna RosendalJoin the conversation on our LinkedIn page

In today's episode on 1st July 2025, we talk about Amazon's foray into India's diagnostics space and whether it can disrupt the industry.

Tonight on The Brian Crombie Hour, Brian interviews Hugh MacNaught.  Hugh introduces Ventripoint Diagnostics, a Toronto-based company that applies AI to cardiac ultrasound for diagnostic purposes, and discusses the company's technology, product, and market positioning. The system was developed to provide a less invasive alternative for children with congenital heart defects. He emphasizes the system's high accuracy and its ability to characterize all four chambers of the heart, particularly the complex right ventricle. Hugh also discusses the system's applications beyond congenital heart defects, including monitoring cancer patients undergoing chemotherapy, heart failure cases, and valve procedures. Pierre Jean from Fournier Capital is also part of this conversation as he expresses excitement about the technology, highlighting its ability to transform echo signals into 3D images of the heart at a fraction of the cost of an MRI. 

Doug Ryan, CEO of Arineta, describes the advancements in cardiac CT imaging technology and how their ultra-fast scanning is revealing more accurate and higher-quality imaging of the heart. Using wide-area coverage and deep learning image reconstruction, the Arineta platform can detect arterial occlusions and coronary plaque buildup, which is a significant risk factor for sudden cardiac events and is often missed when relying solely on calcium scoring. The development of a mobile cardiac CT scanning unit is improving access to this technology, particularly in rural and underserved areas. Doig explains, "What you're trying to do is to stop the most complex organ inside the human body. The human heart translates, rotates, and beats somewhere between 60 and 100 beats per minute. So you really need advanced CT technology that comprises a great many areas, but the most important things are coverage speed and the ability to reconstruct it very quickly." "You're using advanced algorithms like our DLIR, our deep learning image reconstruction, which focuses on high-contrast, high-spatial, low-noise reconstructions that can then be put into what we call a multiplanar format. So you can look at these coronary arteries from all angles and do the diagnostic." "So it's actually a combination of several things. Ultra FAST is, of course, very important because you are literally trying to stop a bird mid-flight and get an accurate picture of it, but it's also the ability to encompass and see the entire heart in a single rotation. So, one of the secrets of the SpotLight and SpotLight Duo is both the ultra-fast rotation and the wide area coverage that we get with our detector system." #Arineta #CTImaging #CardiovascularDiagnostics #Cardiology #DeepLearningImageReconstruction   Arineta.com Listen to the podcast here    

Doug Ryan, CEO of Arineta, describes the advancements in cardiac CT imaging technology and how their ultra-fast scanning is revealing more accurate and higher-quality imaging of the heart. Using wide-area coverage and deep learning image reconstruction, the Arineta platform can detect arterial occlusions and coronary plaque buildup, which is a significant risk factor for sudden cardiac events and is often missed when relying solely on calcium scoring. The development of a mobile cardiac CT scanning unit is improving access to this technology, particularly in rural and underserved areas. Doig explains, "What you're trying to do is to stop the most complex organ inside the human body. The human heart translates, rotates, and beats somewhere between 60 and 100 beats per minute. So you really need advanced CT technology that comprises a great many areas, but the most important things are coverage speed and the ability to reconstruct it very quickly." "You're using advanced algorithms like our DLIR, our deep learning image reconstruction, which focuses on high-contrast, high-spatial, low-noise reconstructions that can then be put into what we call a multiplanar format. So you can look at these coronary arteries from all angles and do the diagnostic." "So it's actually a combination of several things. Ultra FAST is, of course, very important because you are literally trying to stop a bird mid-flight and get an accurate picture of it, but it's also the ability to encompass and see the entire heart in a single rotation. So, one of the secrets of the SpotLight and SpotLight Duo is both the ultra-fast rotation and the wide area coverage that we get with our detector system." #Arineta #CTImaging #CardiovascularDiagnostics #Cardiology #DeepLearningImageReconstruction   Arineta.com Download the transcript here    

Today, I'm joined by Saad Alam, co-founder and CEO of Hone Health.   Hone Health is a longevity care platform combining AI-powered diagnostics, telehealth consults, personalized treatment plans, and specialized physicians for healthspan optimization.   In this episode, we discuss building and training a workforce for new-age medicine.   We also cover:   Normalizing hormone health for both sexes Changing medical education for systemic reform Making premium care accessible to Middle America   Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscribe Follow us on LinkedIn → linkedin.com/company/fittinsider   Hone Health's Website: https://honehealth.com/    -   The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities.   Fitt Talent: https://talent.fitt.co/  Consulting: https://consulting.fitt.co/  Investments: https://capital.fitt.co/    Chapters: (00:00) Introduction (01:10) Current State of Hone Health and Recent Growth (03:30) De-stigmatizing Testosterone and Hormone Optimization (08:05) Market Shift Moments for Men's and Women's Health (10:05) Vision for AI-Enhanced Longevity Care Platform (14:20) Commoditization of Diagnostics and Future of Healthcare (18:30) Competing on Care Delivery vs Diagnostics (22:25) Personal Healthcare Journey and Market Research Insights (24:40) Transition from Telehealth to Comprehensive Longevity Care (29:25) Patient Journey from Symptom Relief to Optimization (32:15) Building and Training Longevity Medicine Workforce (35:40) Changing Medical Education and System Reform (37:20) Making Premium Care Accessible to Middle America (39:10) Conclusion  

Anish Agarwal and Raj Agrawal, co-founders of Traversal, are transforming how enterprises handle critical system failures. Their AI agents can perform root cause analysis in 2-4 minutes instead of the hours typically spent by teams of engineers scrambling in Slack channels. Drawing from their academic research in causal inference and gene regulatory networks, they've built agents that systematically traverse complex dependency maps to identify the smoking gun logs and problematic code changes. As AI-generated code becomes more prevalent, Traversal addresses a growing challenge: debugging systems where humans didn't write the original code, making AI-powered troubleshooting essential for maintaining reliable software at scale. Hosted by Sonya Huang and Bogomil Balkansky, Sequoia Capital Mentioned in this episode: SRE: Site reliability engineering. The function within engineering teams that monitors and improves the availability and performance of software systems and services. Golden signals: four key metrics used by Site Reliability Engineers (SREs) to monitor the health and performance of IT systems: latency, traffic, errors and saturation. MELT data:  Metrics, events, log, and traces. A framework for observability. The Bitter Lesson: Another mention of Nobel Prize  winner Rich Sutton's influential post.

Send us a textWe're thrilled to welcome Eyal Trichter, CEO of Trilogical Technologies, to the show!With over two decades of experience in engineering, R&D, and business development, Eyal is a true leader in the evolution of rolling stock telematics and Remote Condition Monitoring & Diagnostics for the rail industry.

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)Cough as the most significant symptom and burdenImaging bronchiectasis with classic and inflammatory findingsDifferentiating the causes of NCFBE to inform patient carePresentersBrett M. Elicker, MDProfessor of Clinical RadiologyChief, Cardiothoracic Imaging DivisionDepartment of Radiology & Biomedical ImagingUniversity of California, San FranciscoSan Francisco, CaliforniaDavid E. Griffith, MD, ATSF, FACCP, FRSMProfessor of MedicineDivision of Mycobacterial and Respiratory DiseasesDepartment of MedicineNational Jewish HealthDenver, ColoradoProgram page: https://bit.ly/4mZbYsm

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)Cough as the most significant symptom and burdenImaging bronchiectasis with classic and inflammatory findingsDifferentiating the causes of NCFBE to inform patient carePresentersBrett M. Elicker, MDProfessor of Clinical RadiologyChief, Cardiothoracic Imaging DivisionDepartment of Radiology & Biomedical ImagingUniversity of California, San FranciscoSan Francisco, CaliforniaDavid E. Griffith, MD, ATSF, FACCP, FRSMProfessor of MedicineDivision of Mycobacterial and Respiratory DiseasesDepartment of MedicineNational Jewish HealthDenver, ColoradoProgram page: https://bit.ly/4mZbYsm

“We started Cleerly with the intent to make a comprehensive care pathway for evaluation, education, treatment and tracking for heart disease,” said Dr. Jim Min, the company’s founder and CEO. In this Vanguards of Health Care episode, Min sits down with BI analyst Matt Henriksson to discuss Cleerly and its comprehensive management platform that uses AI algorithms to boost the accuracy of interpreting CT scans, avoid false positives and make the diagnosis stage of treating the disease more efficient for doctors and hospitals. They also cover the need to drive the iterative process of clinical studies, including the TRANSFORM randomized trial for screening asymptomatic individuals with the aim of preventing sudden cardiac death.See omnystudio.com/listener for privacy information.

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)Cough as the most significant symptom and burdenImaging bronchiectasis with classic and inflammatory findingsDifferentiating the causes of NCFBE to inform patient carePresentersBrett M. Elicker, MDProfessor of Clinical RadiologyChief, Cardiothoracic Imaging DivisionDepartment of Radiology & Biomedical ImagingUniversity of California, San FranciscoSan Francisco, CaliforniaDavid E. Griffith, MD, ATSF, FACCP, FRSMProfessor of MedicineDivision of Mycobacterial and Respiratory DiseasesDepartment of MedicineNational Jewish HealthDenver, ColoradoProgram page: https://bit.ly/4mZbYsm

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)Cough as the most significant symptom and burdenImaging bronchiectasis with classic and inflammatory findingsDifferentiating the causes of NCFBE to inform patient carePresentersBrett M. Elicker, MDProfessor of Clinical RadiologyChief, Cardiothoracic Imaging DivisionDepartment of Radiology & Biomedical ImagingUniversity of California, San FranciscoSan Francisco, CaliforniaDavid E. Griffith, MD, ATSF, FACCP, FRSMProfessor of MedicineDivision of Mycobacterial and Respiratory DiseasesDepartment of MedicineNational Jewish HealthDenver, ColoradoProgram page: https://bit.ly/4mZbYsm

Bob Roda, President and CEO of HemoSonics, highlights the current blood shortage and the challenges of patient blood management to minimize the need for transfusions. The HemoSonics Quanta Analyzer technology utilizes ultrasound to measure blood viscosity, providing real-time information on the patient's coagulation status and enabling clinicians to make more informed decisions about blood product administration. This approach can be applied in the operating room, emergency rooms, and hospital laboratories to improve patient outcomes and yield cost savings for the healthcare system.  Bob explains, "As a company, we are very centered and focused on helping to shape human healthcare moving forward. Specifically, as it relates to coagulation management, we have a technology that is about five years old, and in layman's terms, it helps to identify what is going on with your blood in terms of coagulation, intraoperatively, and in near real-time. So what does that mean? It means that it is an aid for clinicians as they're making determinations for their patients as to what to do next in terms of managing their bleeding situations."   "Think about patient blood management as a patient-centered, systematic, and evidence-based approach to improving patient outcomes simply by managing and preserving a patient's own blood while promoting safety and ultimately the empowerment of the patient. So what does that mean? What it means is that there is a multifaceted approach in terms of any surgical intervention, where ultimately your own blood, the patient's own blood, is really what's best for them. And so to the extent that you can limit or prevent or get ahead of the need for transfusion, that's ultimately to the benefit of the patient and to the benefit of the healthcare system from an economic perspective." #HemoSonics #Hemostasis #BloodManagement #Quantra #BleedingManagement #MedTech #HealthcareInnovation hemosonics.com Download the transcript here

Bob Roda, President and CEO of HemoSonics, highlights the current blood shortage and the challenges of patient blood management to minimize the need for transfusions. The HemoSonics Quanta Analyzer technology utilizes ultrasound to measure blood viscosity, providing real-time information on the patient's coagulation status and enabling clinicians to make more informed decisions about blood product administration. This approach can be applied in the operating room, emergency rooms, and hospital laboratories to improve patient outcomes and yield cost savings for the healthcare system.  Bob explains, "As a company, we are very centered and focused on helping to shape human healthcare moving forward. Specifically, as it relates to coagulation management, we have a technology that is about five years old, and in layman's terms, it helps to identify what is going on with your blood in terms of coagulation, intraoperatively, and in near real-time. So what does that mean? It means that it is an aid for clinicians as they're making determinations for their patients as to what to do next in terms of managing their bleeding situations."   "Think about patient blood management as a patient-centered, systematic, and evidence-based approach to improving patient outcomes simply by managing and preserving a patient's own blood while promoting safety and ultimately the empowerment of the patient. So what does that mean? What it means is that there is a multifaceted approach in terms of any surgical intervention, where ultimately your own blood, the patient's own blood, is really what's best for them. And so to the extent that you can limit or prevent or get ahead of the need for transfusion, that's ultimately to the benefit of the patient and to the benefit of the healthcare system from an economic perspective." #HemoSonics #Hemostasis #BloodManagement #Quantra #BleedingManagement #MedTech #HealthcareInnovation hemosonics.com Listen to the podcast here

On today's episode, Dr. Mark Costes welcomes Jordan Reiss, Senior Director of Clinical Strategic Development at DEXIS, live from the Thrive Live exhibition hall in Las Vegas. With a background that spans management consulting at KPMG to dental tech innovation, Jordan shares how he found his passion in dentistry and 3D imaging. The conversation explores how CBCT is transforming not just implantology, but also endodontics, orthodontics, and aligner therapy.   Jordan highlights the evolving need for clinician education in CBCT interpretation, the rise of AI-enhanced imaging workflows, and the comprehensive ecosystem DEXIS is building to support diagnostics and patient care. He also shares personal stories about parenting, mission work, and the unexpected roads that lead to a meaningful career. Be sure to check out the full episode from the Dentalpreneur Podcast! EPISODE RESOURCES https://dexis.com https://www.truedentalsuccess.com Dental Success Network Subscribe to The Dentalpreneur Podcast

  How familiar are you with partnerships and collaborations between the laboratory and the diagnostics industry? In this episode Luis is joined by Dr. Andrea Prinzi and Dr. Kristen Smith to explore how partnerships between clinical labs, public health institutions, and the diagnostics industry drive innovation in in-vitro diagnostics (IVDs).  What is the IVD pipeline? From discovery to product launch and beyond, these collaborations improve patient care, accelerate access to new technologies, and enhance public health outcomes. Why breaking silos and fostering inclusive partnerships is essential for the future of diagnostics? Tune in to find out.  Link to article: https://doi.org/10.1016/j.clinmicnews.2025.04.001 Questions? Feedback? Send those to letstalkmicro@outlook.com Want to support the podcast? Here's how: Venmo: https://venmo.com/u/letstalkmicro Buy me a Ko-fi: https://ko-fi.com/letstalkmicro  

In this second episode of our lung cancer miniseries, Jonathan Sackier is joined by David Baldwin, a leading expert in screening, epidemiology, and policy. Baldwin reflects on national screening programmes, groundbreaking trials, and how AI, big data, and evidence-based guidelines are reshaping lung cancer care. Timestamps: 00:00 – Introduction 03:17 – Key takeaways from the UKLS trial 11:10 – Boosting participation in screening studies 17:04 – The Targeted Lung Health Check programme 23:30 – Understanding large datasets in lung cancer epidemiology 32:44 – AI and big data in lung cancer imaging 41:43 – Shaping national guidelines 47:47 – Are we doing enough to prevent lung cancer? 53:06 – Baldwin's three wishes for healthcare

This week, Ferg chats with Greg Mirams, founder of Techion/FECPAK. What started as a tool to do worm egg counts on-farm has evolved into a digital platform that reads samples using AI, returns results in minutes, and is helping farmers tackle drench resistance head-on.They cover the early days of FECPAK, how AI is speeding up diagnosis, what species ID could unlock for breeders, and why post-treatment testing matters more than ever.• Why drench resistance is no longer a “maybe” and what farmers can actually do about it.• How AI now reads worm egg counts in minutes.• The upcoming ability to identify worm species, making treatments far more targeted.• How egg count data is being used to track contamination, inform grazing plans, and map resistance across regions.https://fecpak.com/nzHead Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, and Heiniger Australia and New Zealand. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out Heiniger's product range HERECheck out the MSD range HERECheck out Allflex products HERE

In this special Pride Month episode of Tech It to the Limit, co-hosts Sarah Harper and Elliott Wilson dive into LGBTQ+ health equity, inclusive tech, and leading authentically in healthcare. They're joined by Jason Bellett, Co-Founder and Chief Business Officer at Eko Health, whose intelligent stethoscope is transforming how providers detect heart disease. Jason opens up about his journey as an openly gay founder, the intersection of innovation and equity, and the urgent need for inclusive leadership.Key TakeawaysLGBTQ+ healthcare has come a long way—but the fight for equity and access continues.Eko Health's AI-powered stethoscope enables early heart disease detection through FDA-cleared algorithms and inclusive design.Algorithmic equity matters: representative datasets and diverse health partners are key to reducing bias.Authentic leadership in healthcare requires visibility and courage, especially in today's climate.In the face of policy rollbacks, private sector leaders must step up to build inclusive tech and equitable systems.In this episode:[00:00:00] Pride Month kickoff + queer health visibility[00:01:25] “Holz Check” LGBTQ+ healthcare rights timeline[00:08:27] 10+ health tech companies advancing queer care[00:12:28] Interview with Jason Bellett[00:15:30] What is an intelligent stethoscope?[00:20:15] Equity in AI + reducing algorithmic bias[00:25:35] Eko's role in smart hospitals and virtual care[00:27:46] What Jason wishes he knew 10 years ago[00:31:05] Leading authentically as a gay founder[00:34:14] Advice for LGBTQ+ health tech professionals[00:38:45] Call to action for DEI in healthcare[00:42:22] Spicy Nuggets: Buzzwords, pride, and cootiesResources and LinksJason BellettLinkedIn Eko HealthPride Month SpotlightsFolks Health Plume HealthQueerDocOutCare HealthHoward Brown HealthMazzoni CenterFenway Health Euphoria AppsMyLabBoxFor ThemEquality MD

In this episode of Behind the Breath, Marjorie Cullinan, MSHA, RRT, RRT-NPS, RPFT, Operations Manager of Pulmonary Function Testing at Yale New Haven Hospital, sits down with AARC Vice President of Membership and Customer Care, Monique Kimmel to discuss the importance of AARC resources and networking in the Diagnostics Specialty Section, her journey in adult and pediatric respiratory critical care, and how her mentors help shape her career.Additional Resources AARC Diagnostics Specialty SectionBehind the Breath Video with Marjorie Cullinan and Monique KimmelSend us a textSupport the show

In the third and final episode of our miniseries on infectious disease diagnostics, Jonathan sits down with global diagnostics leader Rosanna Peeling, Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine. Together, they explore the life-saving role of diagnostics in global health, from battling STDs to confronting COVID-19, and examine how equitable access, social innovation, and regulatory reform can transform disease control and pandemic preparedness.   Timestamps: 00:00 – Introduction 06:09 – Rosanna's interest in microbiology 08:12 – The IDC's work 10:52 – Funding for diagnostics 13:30 – Diagnostic testing in low-resource settings 18:21 – Chlamydia research 24:19 – Regulatory approval challenges 29:35 – Social innovation 34:08 – Clinician adaptation 37:10 – Current diagnostic innovations 40:30 – Rosana's three wishes for healthcare

In healthcare, some of the most meaningful innovations happen when the right people are brought together in the right place. True progress depends on systems and infrastructure designed to connect ideas, people, and expertise across sectors. Citylabs 4.0, now open in the heart of Manchester's Knowledge Quarter on the Oxford Road Corridor, was built with exactly that goal in mind. Bringing the NHS, academia, and life sciences organisations into close, purposeful proximity, providing a structural foundation for collaboration at scale. In this special live recording of the pharmaphorum podcast, developed in association with Bruntwood SciTech, Bruntwood SciTech's CSO Dr Kath Mackay, Manchester University NHS Foundation Trust T's Dr Katherine Boylan, and Dr Gillian Dalgliesh from QIAGEN join Deep Dive editor Eloise McLennan onstage at the opening of Citylabs 4.0 to discuss innovation in life sciences and the role of Greater Manchester in accelerating research, industry collaboration, and real-world evidence generation. Join us as we examine how this deliberate integration of healthcare stakeholders in Manchester is establishing new standards for collaboration and advancing patient outcomes through structured knowledge exchange. About the interviewees Dr Kath Mackay Kath Mackay is Chief Scientific Officer of Bruntwood SciTech - a JV between leading property developer Bruntwood, Legal & General, and Greater Manchester Pension Fund - the UK's leading creator and developer of innovation districts driving growth of the UK science and technology sector.  She has a keen interest in growing businesses and infrastructure within the sector, ensuring the UK is the best place to establish and scale a science and tech organisation.   Dr Mackay joined Bruntwood SciTech from the executive board of Innovate UK where she led the team responsible for growing businesses working in the biomedical, health, agriculture, and food sectors, creating and delivering a £800m portfolio of infrastructure, Catapults, grant and loan investments. She is also non-executive director of the Northern Health Science Alliance, the North of England's health partnership, and an elected fellow of the Royal Society of Biology. Dr Katherine Boylan Katherine is Director of Innovation at Manchester University NHS Foundation Trust (MFT), a position she has held since April 2020. This role involves overseeing innovation activities within MFT, as part of the wider Research and Innovation function. Innovation at MFT supports the whole pipeline from ideation, through to evidence generation, and ultimate implementation. She has been a member of the NICE Medical Technologies Advisory Committee since September 2020. Prior to this position, Dr Boylan worked in the University of Manchester for a number of years, most recently as Operations Director for the MRC funded Molecular Pathology Node, and the Trust-funded Diagnostics and Technology Accelerator. Dr Gillian L Dalgliesh, PhD Global Technical lead, Precision Diagnostics Gillian Dalgliesh has worked for QIAGEN for nine years and is based at their Manchester site, which is the global centre of excellence for molecular diagnostic development. QIAGEN partner with many drug companies to develop companion diagnostic (CDx) tests that enable clinical trials and subsequently launches of novel precision medicines. In recent years they have seen a real move beyond oncology into other disease areas such as immune, neurological and metabolic disorders. Dr Dalgliesh's role as global technical lead allows her to leverage her oncology precision medicine experience across the portfolio to bring precision diagnostic products to more patients. She has built her experience in precision medicine/oncology through not only her QIAGEN role but also through seven years working in precision medicine in AstraZeneca and prior to that working as part of the cancer genome project at the Sanger institute. Dr Dalgliesh is also an honorary senior lecturer at University of Manchester where she coordinates and delivers lectures for a QIAGEN sponsored BSc final year elective module ‘The Role of Diagnostics in Medicine'. This is part of a wider outreach role with the University and our NHS hospital. Through these roles she is keen to impact the local UK science community. About Bruntwood SciTech Bruntwood SciTech is the UK's largest dedicated property platform serving the growth of the nation's knowledge economy to become a global science and technology superpower. It is also the leading developer of city-wide innovation ecosystems and specialist environments, helping companies - particularly those in the science and technology sectors - to form, scale and grow A joint venture between Bruntwood, Legal & General and the Greater Manchester Pension Fund (GMPF), Bruntwood SciTech provides high quality office and laboratory space and tailored business support, offering unrivalled access to finance, talent and markets, an extensive clinical, academic and public partner network and a sector-specialist community of more than 1100 companies. Bruntwood SciTech is experienced in creating and developing strategic partnerships with UK regional cities, universities and NHS Trusts to drive economic growth. Its unique structure and funding vehicle more easily deploys long-term patient capital in innovation infrastructure, ensuring local economic benefit and growth. Valued at £1.5bn, Bruntwood SciTech has a portfolio of 5.2m sq ft across 11 campus locations and 31 city centre innovation hubs in Manchester, Cheshire, Birmingham, Leeds, Liverpool, Cambridge and London. It has plans to create a £5bn portfolio by 2033 and has a 2.3m sq ft secured development pipeline. Its campus locations include Alderley Park in Cheshire; West Village in Leeds; Innovation Birmingham; Birmingham Health Innovation Campus in partnership with the University of Birmingham; Melbourn Science Park in Cambridgeshire; Liverpool Science Park as a shareholder in Sciontec Liverpool; White City Deep Tech Campus in partnership with Imperial College London; and a cluster in the heart of Manchester's Oxford Road Corridor knowledge quarter - Manchester Science Park, Citylabs in partnership with Manchester University NHS Foundation Trust (MFT), Circle Square - a joint venture with Vita Group; and the £1.7bn JV partnership with The University of Manchester - Sister, formerly known as IDManchester. Its city centre innovation hubs include Bloc, Bond, 111 Piccadilly, Pall Mall and Manchester One in Manchester; Platform in Leeds; Cornerblock and Centre City in Birmingham; and The Plaza in Liverpool. Website / Twitter / LinkedIn / Instagram

On this episode of Longevity by Design, Dr. Gil Blander sits down with Dr. Evelyne Bischof, President of the Healthy Longevity Medicine Society.  Evelyne discusses her background in internal medicine and oncology and how her work puzzling together patient diagnoses led her to the field of longevity medicine. She highlights the importance of optimizing health span, not just lifespan, and how healthy longevity medicine benefits not only individuals, but population health and the world economy as well.Gil and Evelyne explore the difference between longevity medicine and traditional healthcare. Evelyne explains that longevity medicine uses a broader range of diagnostics, including advanced biomarkers, imaging, and cognitive tests. This approach aims to build a personalized health trajectory for each patient. They also discuss the role of AI in healthcare, with Evelyne expressing hope for faster, AI-driven diagnostics and drug discovery in the future.Finally, they touch upon the Healthy Longevity Medicine Society, its mission to establish longevity medicine as a recognized medical discipline, and the exciting developments in the field, such as the SHARP study at the Sheba Longevity Center. Evelyne emphasizes the importance of being data-driven and encourages listeners to collect and track their own health data. She believes this empowers individuals to make informed decisions about their health and longevity.Guest-at-a-Glance

In this episode of the Tacos & Tech Podcast, host Neal Bloom sits down with CEO of Pictor, a diagnostics company transforming healthcare through proteomics-the science of understanding what the body's proteins are doing right now. They explore how this next-generation technology is shifting the medical world from slow, reactive testing to real-time, accessible diagnostics for both humans and animals. From Jamie's early days at Quest Diagnostics to Pictor's move from New Zealand to San Diego, this episode is a front-row seat to how health innovation really happens. Whether you're building a biotech startup or just curious about how your body actually works, this conversation reveals what's next for diagnostics-and why it matters now more than ever.   Key Topics Covered What proteomics is-and why it matters more than ever The shift from DNA-based tests to real-time protein diagnostics Pictor's expansion to Carlsbad and why San Diego is a healthtech hotspot How regulatory clarity is speeding up innovation Lessons in leadership and conviction from Jamie's founder journey Making diagnostics faster, cheaper, and more personal   Links & Resources Pictor Diagnostics   Connect with Jamie LinkedIn Connect with Neal Bloom LinkedIn Twitter

Savannah Applegate, Ph.D. is a Senior Consultant at Elanco Poultry Food Safety. Dr. Applegate received her B.S. degree in Meat Science from Ohio State University and her M.S. degree and Ph.D. in Applied Food Microbiology from Texas Tech University. Her areas of expertise are meat and poultry food safety, and she specializes in diagnostics and pathogen mitigation.  In this episode of Food Safety Matters, we speak with Dr. Applegate [1:10] about: The importance of diagnostics for ensuring food safety and implementing effective disease management protocols in the poultry industry Common misconceptions among industry about diagnostics and how to effectively implement diagnostic tests on-farm Key first steps to integrating effective diagnostic testing protocols alongside biosecurity programs The difference between serotyping data versus quantitative data, and the importance of both to determining the effectiveness of Salmonella vaccines for poultry Support and solutions offered by Elanco for collecting and interpreting serotyping and quantification data to improve poultry food safety outcomes. Sponsor Elanco We Want to Hear from You!Please send us your questions and suggestions to podcast@food-safety.com

Welcome to Buffalo HealthCast, the official podcast of the University at Buffalo's School of Public Health and Health Professions

Dev Mittar, Ph.D., Scientific Director of the ASM Health Scientific Unit discusses the use of metagenomic next generation sequencing to develop agnostic diagnostic technology, giving scientists and clinicians alike, a tool to diagnose any infectious disease with one single test. He also discusses how the ASM Health Unit is empowering scientists and leveraging microbial science innovations to address critical global health challenges and improve lives worldwide. Ashley's Biggest Takeaways The Division of Research, Innovation and Ventures is a small entrepreneurial arm of BARDA that takes on early-stage projects with high potential of turning into medical countermeasures. Prior to his role as Scientific Director for ASM Health, Mittar worked as a health scientist and program officer at DRIVe, where he focused on advancing high-impact science. He is particularly passionate about his work to develop agnostic diagnostics—a single test that uses metagenomic next generation sequencing to identify any pathogen from 1 clinical sample. Mittar discusses applications for this technology in surveillance (pandemic preparedness), variant detection, AMR and clinical settings (diagnosing complicated infections where etiology is not clearly defined). He also shares how a recent bout with illness emphasized the value and potential of this technology to save money, time, pain and suffering of the patient. Agnostic diagnostics can also help prevent the overuse/misuse of antibiotics, which are key factors in the spread of antimicrobial resistance. Furthermore, when this technology is coupled with the use of metatranscriptomics, it can provide information about the patient's immune profile that can be helpful in developing personalized treatment strategies, as opposed to a one-size-fits-all approach. ASM is organizing around 3 scientific units, ASM Health, ASM Mechanism Discovery and ASM Applied and Environmental Microbiology. These units will empower researchers and scientists to use science make a difference in the world and provide a forum for them to come together to shape the future of the field. Links for This Episode Learn More About ASM's Scientific Units. Join the Conversation on ASM Connect, our online community platform. Browse Volunteer Opportunities. Become an ASM Member. Register for ASM Microbe 2025.

In today's VETgirl online veterinary continuing education podcast, Dr. Michelle Evason, BSc, DVM, DACVIM, MRCVS, Global Director of Veterinary Clinical Education at Antech, and Dr. Jimmy Barr, DACVECC, Chief Medical Officer at Antech, part of Mars Science & Diagnostics, discuss vector borne disease including spectrum of care. Screening dogs for vector-borne disease pathogens, like Lyme and Heartworm, occurs annually in veterinary clinics across the US and Canada. Listen in for updates on innovations and practical pearls on pet-owner communication & shared-decision-making across the diagnostic spectrum of care.Sponsored By: Antech, MARS

Thanks to our Partners, NAPA TRACS, and Today's Class Recorded at the TST Big Event, industry trainers Eric Ziegler and Pete Meier dive into the growing challenges technicians and shop owners face in staying current with technology and why continuous education is no longer optional. The conversation highlights key issues including the liability risks of inadequate training, the double-edged sword of social media as an information source, and the power of peer-to-peer knowledge sharing. Eric and Pete also stress the importance of actively applying what's learned, not just passively consuming information, and how networking with other professionals can accelerate growth. Eric Ziegler, EZ Tech Mentors.  Eric's previous episodes HERE. Pete Meier, Training Manager, Dorman Products. Pete's other episodes HERE Show Notes: Watch Full Video Episode TST Big Event 2025: https://www.tstseminars.org/ Introduction to the Episode (00:00:00) Overview of Training Importance (00:01:03) Cultural Shift in Training (00:03:04) Incentivizing Training (00:04:08) Training Formats and Challenges (00:05:00) Technician Growth and Retention (00:06:55) Advocating for Continuing Education (00:07:40) Financial Commitment to Training (00:08:20) Cultural Commitment to Education (00:09:24) Awareness of Training Resources (00:10:09) Networking at Training Events (00:11:19) Building a Positive Training Culture (00:12:52) Value of Training Experiences (00:14:04) Networking Importance (00:14:38) Training Takeaways (00:14:59) Building a Training Culture (00:18:56) Mentorship in the Industry (00:19:05) Service Information Awareness (00:21:50) Consequences of Ignoring Updates (00:22:39) Importance of Accurate Training (00:26:02) Battery Maintenance and Diagnostics (00:28:17) Technician Homework (00:30:53) Social Media's Role in the Industry (00:31:22) Generational Changes in Automotive Skills (00:33:30) Quality vs. Price in Automotive Services (00:36:40) Vetting Information Sources (00:38:24) Making Training Practical (00:41:19) The Forgetting Curve (00:42:19) Taking Action on Learning (00:43:05) Business Perspective on Training (00:43:43) Changing Technician Compensation (00:44:53) Thanks to our Partner, NAPA TRACS NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS...

This week, Lauren welcomes UI College of Public Health alumnus and recipient of the college's 2024 Outstanding Alumni Award, Dr. Vijay Golla. They discuss his journey into public health that began with his medical training in India, where he became interested in preventive medicine and social medicine. This led him to pursue a Ph.D. in industrial hygiene at the University of Iowa, where he focused his dissertation on assessing pesticide levels and related doses among farm families in Iowa. After graduating, Dr. Golla returned to Western Kentucky University, where he obtained a training grant to support undergraduate and graduate students in environmental health sciences. In his current role as Vice Provost for Research and Health Sciences at Texas A&M, Dr. Golla has been able to significantly increase research funding and expand the university's health science initiatives, which he sees as a critical part of public health's future focus on disease prevention. Dr. Golla emphasizes the importance of field experience, networking, and staying research-active for current public health students and young professionals. He is excited about public health's growing influence and its potential to play a pivotal role in providing personalized preventive healthcare recommendations, much like a vehicle's diagnostic system. A transcript of this episode is available at https://www.public-health.uiowa.edu/news-items/plugged-in-to-public-health-a-conversation-with-dr-vijay-golla/ Have a question for our podcast crew or an idea for an episode? You can email them at CPH-GradAmbassador@uiowa.edu You can also support Plugged in to Public Health by sharing this episode and others with your friends, colleagues, and social networks. #publichealth

In this episode of From First Period to Last Period, Shea shares her harrowing experience with ⁠hyperemesis gravidarum⁠ — a severe and often misunderstood form of morning sickness that made her pregnancy nearly unbearable.⁠Dr. Jenna Kahn⁠ also shares some big personal news: she's in the process of freezing her embryos. She takes us behind the scenes of the emotional and medical steps involved, and what this decision means for her future fertility.Noticed ⁠mid-cycle spotting⁠ and unsure what it means? We break down the possible causes — from harmless hormonal changes to signs you shouldn't ignore — and when it's time to call your doctor.And in a glimpse at the future of reproductive health, we explore how ⁠menstrual blood⁠ could become a powerful diagnostic tool. Meet the companies leading this innovation and learn how their work could revolutionize early detection and care.Hit play now on ⁠⁠Spotify⁠⁠, ⁠⁠Apple Podcasts⁠⁠, ⁠⁠YouTube⁠⁠, or wherever you listen.

Episode: 3014 Measuring Almost Nothing.  Today, we measure almost nothing.

Dr. Gil Blander welcomes Dr. Daniel Durand, Chief Medical Officer at Prenuvo, to Longevity by Design for a deep dive into the future of preventative healthcare. Dr. Durand shares how full-body MRI is redefining early detection by making advanced imaging accessible, non-invasive, and radiation-free. He explains why MRI, as a soft tissue imaging modality, offers unmatched insight into early-stage cancers and chronic conditions.The conversation unpacks misconceptions around overdiagnosis and false positives, challenging the idea that “not knowing” is safer. Dr. Durand outlines how AI-enhanced imaging, paired with structured follow-up care, reduces unnecessary biopsies and improves diagnostic accuracy. He also discusses the emotional and systemic costs and benefits of proactive screening.Looking ahead, Dr. Durand envisions a healthcare model built on data, personalization, and patient empowerment. He argues that gathering better information, earlier, will shift the focus from treatment to prevention and help more people maintain peak health for longer. Guest-at-a-Glance

Like the show? Show your support by using our sponsors.Promotive can help you find your dream job, or help you hire. Touch HERE for more.Need to update your shop systems and software? Try Tekmetric HEREIn this episode, Jeff Compton and Lucas Underwood get real about the realities of shop ownership and the repair industry. Lucas harps on why you need to build better systems and processes, mainly to avoid burnout. They both get heated about the technician pay structure, industry culture, and the crucial need for personal fulfillment and meaning beyond monetary success.00:00 Intense Storms, Tornado Near Miss06:15 "True Champions Plan for Success"10:49 Complex Challenges in Industry Dynamics20:06 Self-Reflection and Employee Turnover25:07 Owner's Struggles with Management30:23 "Chaotic Kitchen Reflections"31:12 Automotive Industry Training Challenges41:23 Welfare System Critique: Misallocation Concerns45:03 Track and Tax Unbilled Services47:12 Business Finance Transparency Needed56:07 Rethinking Success Beyond Money59:04 Career Pathing Concerns Discussed01:03:14 Fishing: A Passionate Escape01:12:29 Navigating Professional Boundaries01:14:36 "Embracing Emotional Connections"01:20:59 Helping Each Other: A Pipe Dream?01:27:13 Eco Diesel Truck Dilemma01:32:17 Online Complaints Over Car Repairs01:38:54 Unnecessary Changes Disrupt Growing Shop01:40:52 Emotion-Free Decision Making01:46:20 "Challenging Stagnant Business Practices"01:52:54 Building Character Through Purposeful Work Follow/Subscribe to the show on social media! TikTok - https://www.tiktok.com/@jeffcompton7YouTube - https://www.youtube.com/@TheJadedMechanicFacebook - https://www.facebook.com/profile.php?id=100091347564232

Session 4 ‘Novel Approaches to Pathogen Detection and Sepsis Diagnostics' from the 5th World Sepsis Congress. Featuring Evdoxia Kyriazopoulou, Thorsten Brenner, Larissa May, Irit Gat-Viks, Olawale Ajose, and Konrad Reinhart as your moderator.

Key Takeaways: Dr. Louis Teulières, a multi-national doctor with an MD and PhD, has been actively involved with ILADS since 2016 due to his research on bacteriophages at the University of Leicester. Frustrated with the limitations of antibiotic treatments for Borrelia, the bacteria that causes Lyme disease, Dr. Teulières explored bacteriophages as a novel diagnostic and therapeutic approach. Due to regulatory challenges in administering phage therapy, Dr. Teulières and his team developed a phage-based test that can directly detect the presence of Borrelia bacteria. This test, marketed by Red Labs in Europe for the past four years, has been used on thousands of patients and can differentiate between early, late-stage, and post-treatment Lyme disease. Dr. Teulières is now working to expand the test's reach in the U.S., seeking partnerships with American clinicians and researchers to validate the test and pursue FDA clearance. The discussion underscores the need for innovative diagnostic tools to improve Lyme disease detection and accelerate healing journeys for patients. About Dr. Louis Teulières: Medical degree from University of Nice, France. Specializations in immunology, hematology, immunopathology, bacteriology, and epidemiology at the Pasteur Institute in Paris and CDC in Atlanta. Former researcher at the Pasteur Institute, contributing to studies on immune and infectious diseases such as HIV. Active member of the immunology team that received the Nobel Prize in 2008 for discovering the HIV virus in 1983. Founder of CMIL clinics in Lisbon and Paris, specializing in immune and infectious diseases, Lyme disease, and neurodegenerative conditions. Co-founder of PHELIX, a charity dedicated to phage-based research and diagnostics in Lyme disease. Collaborates with University of Leicester, St Thomas Hospital in London, and other world-class healthcare professionals. Resources & Links: Follow the latest ILADS updates: ILADS.org Learn more about Dr. Louis Teulières and his research: Red Labs Stay connected with Tick Boot Camp: Website | Instagram | Facebook | YouTube | TikTok | Twitter (X)

In this forward-looking episode, we dive into the evolving frontier of machine vision AI with Maria Greicer, VP of Partnerships at Keymakr. With over 18 years of global experience across the EU, U.S., and Israel, Maria blends a sharp entrepreneurial eye with deep knowledge of medical AI to shape how tomorrow's healthcare technologies are built today. From her early work in information technologies to leading high-impact growth initiatives at AI startups, Maria's career offers a rare look inside the world of healthcare tech innovation. Tune in as we unpack: How visual AI is accelerating diagnostic accuracy in radiology and ultrasound What makes AI in medicine so uniquely powerful in clinical settings Why remote diagnostics and real-time imaging analysis are game-changers The continuous learning loop that makes edge AI smarter every day Whether you're fascinated by smart healthcare, AI diagnostics, or the future of digital medicine, this conversation delivers. Follow Maria and the cutting-edge work happening at Keymakr now! Episode also available on Apple Podcasts: https://apple.co/38oMlMr

Thanks to our Partners, NAPA TRACS, and Today's Class Tim Iezzi and Ira Waldman introduce their upcoming training class, "Labscope Essentials for the Ball Joint Guy," designed to build strong foundational skills in labscope diagnostics. Aimed at bridging the gap between hands-on mechanical work and advanced technology, the class offers practical, hands-on learning with ongoing support. Tim and Ira break down the curriculum, target audience, and the importance of real-world application to reinforce concepts. They also highlight the critical role of continuous education and why shop owner involvement is key to technician growth and long-term success. Tim Iezzi, Iezzi's Auto Service, Reading, PA Ira Waldman, Mallue's Automotive, Manasquan, NJ Watch Full Video Episode TST Big Event 2025: https://www.tstseminars.org/ "Labscope Essentials for the Ball Joint Guy" 9:00 AM - 5:00 PM on May 3-4, 2025. $495 per person (includes food and refreshments) Event Address: MACS Training Facility- 225 S Broad St, Lansdale, PA 19446 (back of the building). Contact us at: (484) 509-1494 or expertechtraining@gmail.com Guest Introductions (00:00:00) Training Class Announcement (00:02:04) Class Focus Discussion (00:03:16) Investment in Training (00:05:07) Hands-On Learning Approach (00:05:47) Understanding Good vs. Bad Data (00:08:40) Foundation of Skills (00:10:48) Target Audience for the Class (00:12:01) Electricity Basics Requirement (00:12:14) Limitless Potential of Labscopes (00:13:10) Remote Refresher Training (00:14:00) Career Pathing and Continuous Education (00:15:16) Testing Techniques for Diagnostics (00:16:32) Supporting Students Post-Class (00:17:12) Creating a Comfortable Learning Environment (00:20:10) Assessments in Training (00:22:18) Hands-On Labs as Assessment (00:24:30) Accountability in Learning (00:26:22) Engaging Shop Owners in Training (00:27:46) Incentives for Technicians (00:27:58) Upcoming Training Classes (00:28:31) Thanks to our Partner, NAPA TRACS NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS on the Web at http://napatracs.com/ Thanks to our Partner, Today's Class Optimize training with Today's Class: In just 5 minutes daily, boost knowledge retention and improve team performance. Find Today's Class on the web at https://www.todaysclass.com/ Connect with the Podcast: -The Aftermarket Radio Network: https://aftermarketradionetwork.com -Follow on Facebook:

In today's VETgirl online veterinary continuing education podcast, Dr. Holly Brown, ACVP discusses the importance of performing in-house diagnostics (IHD) - commonly known as point-of-care (POC) diagnostics - as part of routine patient care and patient differential diagnosis. In-house diagnostics include urinalysis, CBC, serum chemistries, parasitology and cytology evaluations...all key diagnostics that can be performed at the clinic with the resources you have! Tune in to learn more about the advancements and benefits of performing in-house diagnostics.Sponsored By: Antech, MARS

Lauren Rosenberg, a highly experienced Physician Associate, has dedicated nearly two decades to Internal Medicine and Health Optimization. Driven by a passion for preventative care, Lauren founded Vent Health to shift the focus from disease treatment to prevention. She specializes in a personalized approach that blends genetics, epigenetics, biomarkers, and lifestyle factors to tailor health interventions that extend and optimize each patient's health span. Lauren's practice includes prescribing peptides (GLP, CLP/GIP) for weight loss, insulin resistance, pre-diabetes, etc.  This episode concentrates on all the questions about GLP's, the prescription based Ozempic and others, as well as the Compound Pharmacy GLP's that can often times be less expensive.  Heather and Lauren also cover the common side effects, and how to manage them. In this episode you will learn other health benefits of these peptides, and who can benefit from them as well as practical tips for getting started on GLP-1 Therapy. Lauren is a frequent speaker at the Age Management Medicine Group (AMMG) and the American Academy of Anti-Aging Medicine (A4M) conferences.  Lauren's practice includes Cardiology prevention: Diagnostics and AI analysis to detect dangerous plaque and calcium; advanced lipid testing and cardiovascular genetics Longevity biomarkers: DNA methylation for biological age, VO2 max testing, Telomere health; Therapeutic plasma exchange Cancer prevention: methylated DNA screens, preventative MRIs, tumor marker testing. We will have Lauren back to discuss all these other longevity and optimum health subjects. This episode concentrates on the information pertaining to Peptides, GLP's etc as they are so popular right now. If you want to contact Lauren for more info, you can reach her via her site: https://myventhealth.com and go to the contact page. Or email: vent@myventhealth.com Social Media:  IG: https://www.instagram.com/iamheathert/            You Tube: https://youtube.com/@iamheathert?si=ZvI9l0bhLfTR-qdo Learn more about your ad choices. Visit megaphone.fm/adchoices

Is America REALLY less healthy than it used to be? Or is that just a myth?  Lately, the Make America Healthy Again (MAHA) movement has been romanticizing the past—but was it really a "healthier" time?